Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients

Author： Smith John   Vukelja Svetislava   Rabe Amy   Wentworth-Hartung Nicole   Koutrelakos Nicholas   Shao Spencer   Whittaker Thomas   Wang Yunfei   Asmar Lina   McDowell Diane   Mukhopadhyay Pralay   O’Shaughnessy Joyce  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.142, Iss.2, 2013-11, pp. : 381-388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer

By Albertsson M.   Johansson B.   Friesland S.   Kadar L.   Letocha H.   Frykholm G.   Wagenius G.  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 407-412

Humana Press, Inc

Access to resources Recommend Favorite

A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer

By Modi Shanu  

Breast Cancer Research and Treatment, Vol. 90, Iss. 2, 2005-03 ,pp. : 157-163

Springer Publishing Company

Access to resources Recommend Favorite

Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

By Gasparini Giampietro   Gion Massimo   Mariani Luigi   Papaldo Paola   Crivellari Diana   Filippelli Gianfranco   Morabito Alessandro   Silingardi Vittorio   Torino Francesco   Spada Antonella   Zancan Matelda   Sio Livia   Caputo Antonio   Cognetti Francesco   Lambiase Antonio   Amadori Dino  

Breast Cancer Research and Treatment, Vol. 101, Iss. 3, 2007-03 ,pp. : 355-365

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane

By Smorenburg C.H.   Bontenbal M.   Seynaeve C.   Zuylen C.v.   Heus G.d.   Verweij J.   Wit R.d.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 1, 2001-03 ,pp. : 83-87

Springer Publishing Company

Access to resources Recommend Favorite

A Cancer Research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen

By Johnston S.   Gumbrell L.   Evans T.   Coleman R.   Smith I.   Twelves C.   Soukop M.   Rea D.   Earl H.   Howell A.   Jones A.   Canney P.   Powles T.   Haynes B.   Nutley B.   Grimshaw R.   Jarman M.   Halbert G.   Brampton M.   Haviland J.   Dowsett M.   Coombes R.  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 4, 2004-04 ,pp. : 341-348

Springer Publishing Company

Access to resources Recommend Favorite